Assignee
ALTRUBIO INC
US·2 granted patents·5 pending applications·1 citations·filing 2021–2025
Top patents by PatentIndex Score
7 records- 0184US2025092151A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2024·Application pending·0 cites
- 0283US11897964B2Anti-PSGL-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Granted Feb 13, 2024·1 cites·5 claims
- 0379US2024084028A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 0477US2024124604A1Anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 0571US2022112302A1Tetravalent anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Application pending·0 cites
- 0662US12290565B2Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancersALTRUBIO INC·Filed 2022·Granted May 6, 2025·0 cites·23 claims
- 0752US2026053914A1Methods of using anti-psgl-1 antibodies in combination with jak inhibitors to treat t-cell mediated inflammatory diseases or cancersALTRUBIO INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →